RecruitingPhase 1NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Studying Germ cell tumor of testis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xencor, Inc.
- Intervention
- XmAb541(biological)
- Enrollment
- 282 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2024 – 2028
Study locations (16)
- City of Hope, Duarte, California, United States
- Stanford, Palo Alto, California, United States
- University of California, San Francisco, California, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
- University of Chicago Medical Center, Chicago, Illinois, United States
- Indian University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States
- Karmanos Cancer Institute, Detroit, Michigan, United States
- The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Montefiore Einstein Comprehensive Cancer Center, The Bronx, New York, United States
- The Ohio State University, Columbus, Ohio, United States
- OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
- SCRI Oncology Partners, Nashville, Tennessee, United States
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06276491 on ClinicalTrials.govOther trials for Germ cell tumor of testis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07498959Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular CancerSahlgrenska University Hospital
- RECRUITINGPHASE1NCT07218913Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell TumorsCity of Hope Medical Center
- RECRUITINGPHASE2NCT06866964A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving ChemotherapyWake Forest University Health Sciences
- RECRUITINGPHASE2NCT06932458A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal MetastasesWestern University, Canada
- RECRUITINGNANCT05588700Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor PatientsCentre Leon Berard
- RECRUITINGNCT06309745THERApy De-escalation for TESTicular CancerQueen Mary University of London
- RECRUITINGNANCT06133543Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular CancerHeinrich-Heine University, Duesseldorf
- RECRUITINGNCT05670938Follow-up After Surgery for Testicular CancerErasmus Medical Center